Skip to main navigation Skip to search Skip to main content

Clinical Characteristics of Anti-Synthetase Syndrome: Analysis From the Classification Criteria for Anti-Synthetase Syndrome Project

  • CLASS project participating investigators
  • University of Pittsburgh
  • Nippon Medical School
  • Hospital Clínico Universidad de Chile
  • Department of Internal Medicine and Therapeutics
  • MRC Epidemiology Unit
  • Royal National Hospital for Rheumatic Diseases
  • Centro Hospitalar do Baixo Vouga
  • University of Catania
  • University of Chicago
  • University of California, Los Angeles
  • Perelman School of Medicine & Corporal Michael J. Crescenz Department of Veterans Affairs Medical Center
  • Instituto Nacional de Enfermedades Respiratorias
  • Tosei General Hospital
  • Vall d'Hebron University Hospital
  • National Institutes of Health
  • Università di Milano Bicocca
  • Stanford University
  • Universitat Duisburg-Essen
  • The Karolinska Institute
  • University Medical Center Göttingen
  • McGill University
  • University of Pennsylvania
  • University of Sydney
  • Brigham and Women's Hospital
  • Royal Wolverhampton Hospitals NHS Trust
  • Nizam's Institute of Medical Sciences
  • University and AO Spedali Civili
  • Università di Bari
  • University of Cagliari
  • Hospital Universitario Ramón y Cajal
  • Vita-Salute San Raffaele University & IRCCS San Raffaele Hospital
  • Philipps-Universität Marburg
  • Instituto Nacional del Torax
  • Università degli Studi di Parma
  • Department of Rheumatology
  • North Bristol NHS Trust

Research output: Contribution to journalArticlepeer-review

32   Link opens in a new tab Citations (SciVal)

Abstract

Objective: Anti-synthetase syndrome (ASSD) is a rare systemic autoimmune rheumatic disease (SARD) with significant heterogeneity and no shared classification criteria. We aimed to identify clinical and serological features associated with ASSD that may be suitable for inclusion in the data-driven classification criteria for ASSD. Methods: We used a large, international, multicenter “Classification Criteria for Anti-synthetase Syndrome” (CLASS) project database, which includes both patients with ASSD and controls with mimicking conditions, namely, SARDs and/or interstitial lung disease (ILD). The local diagnoses of ASSD and controls were confirmed by project team members. We employed univariable logistic regression and multivariable Ridge regression to evaluate clinical and serological features associated with an ASSD diagnosis in a randomly selected subset of the cohort. Results: Our analysis included 948 patients with ASSD and 1,077 controls. Joint, muscle, lung, skin, and cardiac involvement were more prevalent in patients with ASSD than in controls. Specific variables associated with ASSD included arthritis, diffuse myalgia, muscle weakness, muscle enzyme elevation, ILD, mechanic's hands, secondary pulmonary hypertension due to ILD, Raynaud phenomenon, and unexplained fever. In terms of serological variables, Jo-1 and non–Jo-1 anti-synthetase autoantibodies, antinuclear antibodies with cytoplasmic pattern, and anti-Ro52 autoantibodies were associated with ASSD. In contrast, isolated arthralgia, dysphagia, electromyography/magnetic resonance imaging/muscle biopsy findings suggestive of myopathy, inflammatory rashes, myocarditis, and pulmonary arterial hypertension did not differentiate between patients with ASSD and controls or were inversely associated with ASSD. Conclusion: We identified key clinical and serological variables associated with ASSD, which will help clinicians and offer insights into the development of data-driven classification criteria for ASSD. (Figure presented.).

Original languageEnglish
Pages (from-to)477-489
Number of pages13
JournalArthritis & Rheumatology
Volume77
Issue number4
Early online date28 Oct 2024
DOIs
Publication statusPublished - 30 Apr 2025

Data Availability Statement

The data underlying the findings reported herein are available on a reasonable request fromthe corresponding author

Funding

Supported by the American College of Rheumatology, EULAR, and Intramural Research Program project ZIA\u2010ES101081 of the National Institute of Environmental Health Sciences, NIH.

FundersFunder number
American College of Rheumatology
National Institutes of Health
National Institute of Environmental Health Sciences
European League Against RheumatismZIA‐ES101081

    Fingerprint

    Dive into the research topics of 'Clinical Characteristics of Anti-Synthetase Syndrome: Analysis From the Classification Criteria for Anti-Synthetase Syndrome Project'. Together they form a unique fingerprint.

    Cite this